175 related articles for article (PubMed ID: 37916907)
21. Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
de Salazar A; Viñuela L; Fuentes A; Teyssou E; Charpentier C; Lambert-Niclot S; Serrano-Conde E; Pingarilho M; Fabeni L; De Monte A; Stefic K; Perno CF; Aguilera A; Falces I; Delgado R; Fernandes S; Diogo I; Gomes P; Paraskevis D; Santoro MM; Ceccherini-Silberstein F; Marcelin AG; Garcia F
Clin Infect Dis; 2023 May; 76(9):1628-1635. PubMed ID: 36571282
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Consequences of Antiretroviral Therapy.
Diggins CE; Russo SC; Lo J
Curr HIV/AIDS Rep; 2022 Apr; 19(2):141-153. PubMed ID: 35299263
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with obesity in the Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) cohort: an observational cross-sectional analysis.
Savinelli S; De Francesco D; Feeney ER; Babalis D; Bagkeris E; Post FA; Boffito M; Williams I; Vera J; Johnson M; Anderson J; Sachikonye M; Winston A; Sabin C; Mallon P
HIV Med; 2020 Aug; 21(7):441-452. PubMed ID: 32311831
[TBL] [Abstract][Full Text] [Related]
24. Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug.
Pantazis N; Papastamopoulos V; Antoniadou A; Adamis G; Paparizos V; Metallidis S; Sambatakou H; Psichogiou M; Chini M; Chrysos G; Panagopoulos P; Sipsas NV; Barbunakis E; Gogos C; Touloumi G;
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016299
[TBL] [Abstract][Full Text] [Related]
25. Re-evaluating the relationship between youth with HIV and BMI in an age of increasing rates of overweight and obese youth.
Hill SV; Hao J; Newlin-Bradner M; Long DM; Budhwani H; Simpson T
BMC Res Notes; 2024 Apr; 17(1):97. PubMed ID: 38561785
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of second-generation integrase strand-transfer inhibitor-based regimens for antiretroviral-experienced people with HIV who had viral rebound.
Chen GJ; Sun HY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Lin KY; Liu WC; Su YC; Hung CC
J Microbiol Immunol Infect; 2023 Oct; 56(5):988-995. PubMed ID: 37574435
[TBL] [Abstract][Full Text] [Related]
27. No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adults.
Burns JE; Stirrup O; Waters L; Dunn D; Gilson R; Pett SL
HIV Med; 2022 Mar; 23(3):294-300. PubMed ID: 34634168
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral therapy in older people with HIV.
Richterman A; Sax PE
Curr Opin HIV AIDS; 2020 Mar; 15(2):118-125. PubMed ID: 31990705
[TBL] [Abstract][Full Text] [Related]
29. Changes in Body Mass Index Over Time in People With and Without HIV Infection.
Lam JO; Leyden WA; Alexeeff S; Lea AN; Hechter RC; Hu H; Marcus JL; Pitts L; Yuan Q; Towner WJ; Horberg MA; Silverberg MJ
Open Forum Infect Dis; 2024 Feb; 11(2):ofad611. PubMed ID: 38323078
[TBL] [Abstract][Full Text] [Related]
30. Obesity among women with HIV.
Millman N; Koethe JR; Erlandson KM
Curr Opin HIV AIDS; 2024 Jan; 19(1):30-34. PubMed ID: 37909915
[TBL] [Abstract][Full Text] [Related]
31. Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort.
Grabar S; Potard V; Piroth L; Abgrall S; Bernard L; Allavena C; Caby F; de Truchis P; Duvivier C; Enel P; Katlama C; Khuong MA; Launay O; Matheron S; Melica G; Melliez H; Meynard JL; Pavie J; Slama L; Bregigeon S; Tattevin P; Capeau J; Costagliola D
J Antimicrob Chemother; 2023 Mar; 78(3):757-768. PubMed ID: 36683307
[TBL] [Abstract][Full Text] [Related]
32. Comparison of weight gain after antiretroviral switch to integrase strand transfer inhibitor or tenofovir alafenamide-based therapy.
Sjaarda A; Bernstein A; Sparks A; Saber S; Siegel M
Infection; 2022 Apr; 50(2):407-412. PubMed ID: 34449049
[TBL] [Abstract][Full Text] [Related]
33. An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor-based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1.
Evitt LA; Nanji S; Grove RA; Okoli C; van Wyk J; Snedecor SJ
AIDS Res Ther; 2023 Mar; 20(1):17. PubMed ID: 36949442
[TBL] [Abstract][Full Text] [Related]
34. Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women.
Kerchberger AM; Sheth AN; Angert CD; Mehta CC; Summers NA; Ofotokun I; Gustafson D; Weiser SD; Sharma A; Adimora AA; French AL; Augenbraun M; Cocohoba J; Kassaye S; Bolivar H; Govindarajulu U; Konkle-Parker D; Golub ET; Lahiri CD
Clin Infect Dis; 2020 Jul; 71(3):593-600. PubMed ID: 31504324
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
[TBL] [Abstract][Full Text] [Related]
36. Weight gain and integrase inhibitors.
Eckard AR; McComsey GA
Curr Opin Infect Dis; 2020 Feb; 33(1):10-19. PubMed ID: 31789693
[TBL] [Abstract][Full Text] [Related]
37. Country of birth is associated with antiretroviral therapy choice in treatment-naive persons with HIV in France.
Palich R; Hentzien M; Hocqueloux L; Duvivier C; Allavena C; Huleux T; Delobel P; Makinson A; Rey D; Cuzin L;
AIDS; 2023 Jul; 37(9):1459-1466. PubMed ID: 37115905
[TBL] [Abstract][Full Text] [Related]
38. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.
Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD;
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):50-8. PubMed ID: 26352511
[TBL] [Abstract][Full Text] [Related]
39. Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy.
Bourgi K; Rebeiro PF; Turner M; Castilho JL; Hulgan T; Raffanti SP; Koethe JR; Sterling TR
Clin Infect Dis; 2020 Mar; 70(7):1267-1274. PubMed ID: 31100116
[TBL] [Abstract][Full Text] [Related]
40. Disparities in Integrase Inhibitor Usage in the Modern HIV Treatment Era: A Population-Based Study in a US City.
Spinelli MA; Hessol NA; Schwarcz SK; Scheer S; Gandhi M; Chin Hsu L
Open Forum Infect Dis; 2021 Jul; 8(7):ofab139. PubMed ID: 34250184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
